Genomadix Cube CYP2C19 System
510(k) K220026
Active
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK220026 | Date21 Mar 2023 | StatusActive |
Official records
- FDA 510(k) database K220026
From the FDA record
- Received by the FDA
- 5 Jan 2022
- FDA decision
- 21 Mar 2023 (Substantially Equivalent)
- FDA review time
- 440 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- NTI
- Device class
- Class II
- Regulation
- 21 CFR Part 862.3360
- Advisory committee
- Clinical Toxicology
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Genomadix Cube CYP2C19 System is a Drug Metabolizing Enzyme Genotyping System designed for molecular genotyping of the CYP2C19 gene. It automates DNA extraction from buccal samples, PCR amplification, and fluorescence-based detection of CYP2C19 alleles to assess genetic variations linked to drug metabolism.
This system is a portable, sample-to-result thermal cycling instrument intended for use in clinical toxicology settings. Supplied as a single-use or reusable component system (depending on module configuration), it generates results in approximately one hour. The device is FDA 510(k)-cleared under classification II (NTI product code) and operates without MRI restrictions. Storage and handling follow standard molecular diagnostic protocols.
Devices cleared under K220026
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| Genomadix Cube CYP2C19 | 2 | G257ASM000960 | On the market | |
| Genomadix Cube CYP2C19 | 2 | G257ASM001160 | On the market | |
| Genomadix Cube CYP2C19 | 2 | G257ASM000990 | On the market | |
| Genomadix Cube CYP2C19 | 2 | G257ASM001010 | On the market | |
| Genomadix Cube CYP2C19 | 2 | G257ASM001030 | On the market |
Similar devices
Other devices filed under FDA product code NTI (Drug Metabolizing Enzyme Genotyping Systems).
- xTAG CYP2D6 Kit v3 by Luminex Molecular Diagnostics, Inc.
- INVADER UGT1A1 MOLECULAR ASSAY by Third Wave Technologies, Inc.
- XTAG CYP2D6 Kit V3 (Including TDAS CYP2D6 Software) by Luminex Molecular Diagnostics, Inc.
- SPARTAN RX CYP2C19 TEST SYSTEM by Spartan Bioscience, Inc.
- AMPLICHIP CYP450 TEST, MODEL 04381866190 by Roche Molecular System, Inc.
- ROCHE AMPLICHIP CYP450 TEST by Roche Molecular System, Inc.
- VERIGENE CYP2C19 NUCLEIC ACID TES (2C19) by NANOSPHERE, INC.
- INFINITI CYP2C19 ASSAY by AUTOGENOMICS, INCORPORATED